TSPO and Huntington disease: Several PET studies, using the ligand translocator protein (TSPO), that is selectively expressed by activated microglia, have demonstrated that microglia activation correlates with disease severity in HD patients and represents one of the earliest clinical biomarkers of HD5,6.